Brookfield, WI - (NewMediaWire) - March 01, 2019 - Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announces a U.S. distribution agreement for their Brain Armor® brand with Threshold® Enterprises, Ltd. This agreement allows Threshold to distribute Brain Armor® products throughout all 50 states in the U.S. Recognized as one of the largest manufacturers and distributors of nutritional supplements and other natural products, Threshold offers more than 450 brands, 18,000 products and distributes to 10,000+ retailers throughout the U.S. and Puerto Rico. This distribution agreement will greatly benefit Brain Armor® Inc., a Trident Brands subsidiary, in its ongoing efforts to achieve country wide distribution and continue its effort to be the market leader in the cognitive health supplement industry.“We are very pleased to have established a national distribution agreement with Threshold Enterprises, Ltd. Their experience and successful track record in distributing high quality supplements in the United States is well known and will be instrumental in growing the Brain Armor® brand as we continue to expand internationally. The entire Brain Armor team is very excited to work with Threshold to make Brain Armor® the brain supplement of choice,” says Mark Cluett, COO of Trident Brands Inc.“Threshold looks forward to representing Brain Armor® across our wide distribution network. We are very impressed with this state of the art brain health supplement line and their scientific and clinical approach. With the help of the entire team at Threshold, we believe that Brain Armor® will be a major player in the brain health supplement market,” says Threshold VP of Sales, Roy McDonald.About Brain Armor® Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play. Our products are clinically-proven dietary supplements formulated with omega-3, healthy fats and vital nutrients, designed to support structural brain health and performance. Brain Armor products are vegetarian, made in the USA and are a regular part of many professional and elite amateur athlete and team conditioning programs. Brain Armor Inc. is a subsidiary of Trident Brands Incorporated (OTCQB: TDNT -- tridentbrands.com).For more information on Brain Armor®, please visit www.brain-armor.comAbout Threshold Enterprises, Ltd.Founded in 1978, Threshold Enterprises, Ltd, shares a vision to empower wellness on a global scale by providing fine-quality dietary supplements and nutritional education. Recognized as one of the largest manufacturers and distributors of nutritional supplements and other natural products, Threshold offers more than 450 brands and 18,000 products distributed throughout all 50 states, as well as in international markets. Threshold is dedicated to holistic healthcare, an approach based on treating the entire body, in an effort to achieve optimum wellness. With more than 40 years of experience, Threshold is an honored recipient of awards for the quality of its products, outstanding customer service, educational-based marketing, great deals and discounts, and a successful history of industry advocacy. For more information, please visit www.thresholdenterprises.comAbout Trident Brands, Inc.Trident Brands Incorporated is a publicly-traded nutraceutical company (OTCQB: TDNT), structured to rapidly develop private label, control label, brand label and proprietary ingredient platforms in the dynamic active nutrition, dietary supplement and functional ingredient categories. For more information, please visit www.tridentbrands.com.Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable ...
MIRAMAR, FL - (NewMediaWire) - March 01, 2019 - Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the information for its investor conference call, is now available to listen and read on our website www.generex.com.The call updated investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, discussed the company’s financing plans relating to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Topics that were covered include:Potential Acquisition of 13 Hospitals as well as Hospital IT and Management companyPotential Acquisition of World Class Nutraceutical CompanyPotential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patientsAcquisition of Direct to Patient End to End Pharmacy BusinessUpdate on Fuse Medical AcquisitionUpdate on Medisource Partners AcquisitionUpdate on Pantheon AcquisitionUpdate on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public StrategyAcquisition plans for NGIO Merger with Company with Synergistic PlatformsNGIO Acquisition of World Class IPDiscussion of financial and legal issueAbout Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ), and dedicated call center.Cautionary Note Regarding Forward-Looking StatementsThis release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is ...
Seattle, WA - (NewMediaWire) - March 01, 2019 - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) and its innovative wellness product line.Most cannabis investors are focused on the medical and recreational cannabis markets, but many ancillary markets are experiencing equally impressive growth. While cannabis industry could hit nearly $150 billion over the coming years, the global wellness industry is already worth upwards of $4 trillion and personal care products generate more than $1 trillion in revenue-an enormous market by anyone's measure.The Yield Growth Corp. is uniquely positioned to capitalize on these ancillary markets with more than 70 wellness products in its pipeline, 29 products registered with Health Canada, and 11 provisional patents filed in the United States.Click here to receive an investor presentation and corporate updatesCFN Media caught up with Yield Growth at the O'Cannabis Conference & Expo in Vancouver:Cannot view this video? Visit:https://www.youtube.com/watch?v=-UZGSm1hM74Follow this link to see the interview: https://www.cannabisfn.com/cfnvideo/?id=vAjwFFwcCannabis in SkincareThe global skincare market is projected to reach $135 billion by 2021, according to Lucintel, driven by increasing consumer awareness. Many skincare brands are also launching multi-functional products that combine beauty benefits, such as anti-aging or anti-blemish properties, and functional benefits, such as protection from the sun or anti-inflammation properties. These functional products are expected to experience the most growth over time.Most hemp skincare products use hemp seed extracts that are naturally rich in omega-6 and omega-3 fatty acids. These compounds naturally hydrate the skin by forming a protective seal over the surface, providing benefits similar to olive oil and other natural oils. Unlike cannabis extracts, hemp seeds do not contain any psychoactive tetrahydrocannabinol (THC) and small quantities of cannabidiol (CBD) that could provide anti-inflammatory benefits. Conversely, Yield Growth's Urban Juve brand utilizes hemp root oil in its line of skin and body care products.According to Hemp Business Journal, the hemp industry surpassed $1 billion in revenue last year. Personal care, the second largest segment of the industry after supplements, generated nearly $200 million in revenue last year. These trends underscore the widespread popularity that hemp has enjoyed across the skincare and wider beauty industry-popularity that investors should consider when diversifying their portfolios.Click here to receive an investor presentation and corporate updatesUrban Juve's ApproachYield Growth's Urban Juve subsidiary has already launched more than ten hemp-based skincare products, including six newly launched face mists and ritual oils. By this summer, the company hopes to have launched more than 30 different products targeting the broader $4.2 trillion wellness industry. The team has a total pipeline of more than 60 wellness formulas, 29 products registered with Health Canada, and 11 provisional patents in the United States.The company's overarching focus is on hemp root oil rather than hemp seed oil. While hemp seed oil provides many benefits, hemp root oil includes alkaloids, ketones, and terpenes that enhance absorption and provide other anti-inflammatory benefits. These properties are widely published in ancient Chinese and Indian literature, but hemp root oil has only recently become more widely known in the Western world.A 1971 study found that many of the terpenes found in the above ground part of the plant are also found in the root, with some minor terpenes in much higher concentrations. Terpenes are known penetration enhancers or natural absorption promoters and are considered the most highly advanced and proven category of compounds for that purpose. The high bioavailability of Hemp Root Oil is due to the ...
New York, NY - (NewMediaWire) - March 01, 2019 - KYN Capital Group Inc. (OTC: KYNC) announced today that new CEO, Ms. Maria Daniels, is actively working with the note holders and larger shareholders to retire larger debts and shares. She is also diligently working for potential JVs. and acquisitions, which she plans to close before the end of the 1st quarter 2019.Maria Daniels stated, “We look forward to make some major updates within next few weeks that will increase the shareholder value.”About KYN Capital GroupKYN Capital Group, Inc. (OTC: KYNC) is a holding company of diverse companies with a focus in sustainable agriculture, nutraceuticals, and alternative energy. KYN Capital Group, Inc. also offers technical services geared for protection in corporate computing and security applications for cloud. http://kyncapitalgroup.com/. Notice Regarding Forward-Looking StatementsThis news release contains forward-looking statements, which reflect our views with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. KYN Capital disclaims any obligation to update any forward-looking statement made herein.Contact Information: Susan Williams, PR Coordinator KYN Capital Group, Inc. 535 Fifth Avenue, 4th Floor New York, NY 10017 email: info@kyncapitalgroupinc.com
West Palm Beach, FL - (NewMediaWire) - March 01, 2019 - Ethema Health Corporation (OTCQB: GRST) (“Ethema” “GRST” or the “Company”), a provider of healthcare services, today announced that it has signed a letter of intent to purchase a 33.33% interest in Local Link Wellness, LLC (“Local Link”), a mental health and wellness provider with offices located in Melville, NY and East Mauritius, NY. Local Link provides trauma informed counselling services through licensed therapists and case management services for New York and New Jersey based employee groups, including large uniformed and construction patient populations. Additionally, Local Link provides members assistance services for construction unions, including prevention, wellness, and mental health trainings, as well as referrals to appropriate levels of care concerning substance use disorder and mental Health services when indicated after assessment. Ethema’s subsidiary, Addiction Recovery Institute of America, LLC (ARIA), will work jointly with Local Link to promote health and wellness plans to employee groups.There is a growing demand for specialized and comprehensive programs focused on wellness, mental health, and substance abuse. Work place incidents related to wellness concerns are growing rapidly and the cost of care associated with treatment is exploding. These issues are all generally related and a coordinated approach is necessary for effective treatment and cost reduction. “At Ethema, we know what needs to be done to deliver the services necessary to treat substance use disorders. Local Link will be a key partner in helping us get the message out to employers faced with wellness issues in the workplace and help with the delivery of services,” said Shawn Leon, President and CEO of Ethema Health Corporation. “We look forward to working together and providing solutions to employees facing these difficult issues”. "It has become abundantly clear to us, through the years of working in members assistance, that the way to best help those in need is for longer term support, involving, professionals, family and peers with a sustained and tracked treatment protocol,” said Mary Fogarty, President of Local Link. “As we have come to know the leadership at Ethema, we have come to know that we are ethically aligned and we are pleased to be a part of the continued care, for sustainable outcomes. We look forward to partnering with Mr. Leon and the Ethema team, whose profound understanding of the behavioral healthcare space will enhance our mission of providing therapeutic and holistic treatment to patients in need.”About Ethema Health CorporationEthema Health Corporation (OTCQB: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last six years and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques with its expansion in the United States. The Company currently has under twenty employees and operates in West Palm Beach, Florida. For more information you can visit our website at www.ethemahealth.com and www.ariafl.comAbout Local Link Wellness, LLCLocal Link has two offices that provide comprehensive mental health counseling for both adult and adolescents, falling under the scope of practices of state licensed LCSW’s. All services provided by Local Link are trauma informed. The Company offers support for the family as well as for the identified client. For more information on Local Link, visit the Company’s website at www.llwcenters.com.Notice Regarding Forward-Looking StatementsThe information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed ...
SAN FRANCISCO, CA, Feb. 28, 2019 (NewMediaWire) -- APT Systems, Inc. (OTC PINK - APTY), a publicly traded, fully reporting fintech company, announced it is reorganizing its authorized share structure and the CEO will be returning to the treasury from personal holdings, 47 Million common shares.The Company filed its preliminary Schedule Form 14C filing as part of the next steps to complete an increase in authorized shares to help attract and secure direct investment from accredited investors for its newest subsidiary, AUREX Trading and Recovery Inc.While embracing its newest revenue opportunity of acquiring e-scrap for precious metal recovery, management of APT Systems also reaffirms its commitment to building financial platforms and further shaping the founder’s vision of delivering modern tools to modern traders. We appreciate and value the ongoing support of our shareholders.About APT Systems Inc.: APT Systems Inc. is a financial technology company that is developing platforms, including trader access to proprietary charting tools, via the KenCharts application, and plans to launch its innovative trading application, Intuitrader. Verifundr is an escrow and payments platform and Tyrtrade is an interchange for minting and delivering Spera, a stable coin. Management also strategically reviews other compatible financial businesses which demonstrate strong growth potential. We are continuing our diligent search for software products and partners that would enhance our operations. Management launched its subsidiaries SNAPT Games, Inc. and RCPS Management, Inc. to further facilitate new products, acquisitions and long-term goals. AUREX Trading and Recovery is leveraging industry-leading recycling technology to provide liquidity and pricing transparency to the precious metals recovery industry.Disclaimer - Forward Looking Statements: This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements; projected events in this press release may not occur due to unforeseen circumstances, various factors, and other risks identified in a company's annual report on Form 10-K and other filings made by such company. APT Systems, Inc (APTY) may opt to also disseminate information about itself, including the results of its operations and financial information, via social media platforms such as Facebook, LinkedIn, and Twitter.On Twitter follow @APTYsysGlenda Dowie, CEO at 415-200-1105Email: info@aptsystemsinc.comLinks to Investor Information: http://AUREXtrading.comhttps://Sperastablecoin.comhttp://www.aptsystemsinc.com/online-investor-kit-for-apt-systems-inc-apty/
Company to Host Conference Call on Thursday, February 28, 2019 at 4:30 p.m. ETBOSTON, Feb. 28, 2019 (NewMediaWire) -- Zoom Telephonics, Inc. (“Zoom” or “the Company”) (OTCQB: ZMTP), a leading producer of cable modems and other communication products, today reported financial results for its 2018 fourth quarter and year ended December 31, 2018.Financial Highlights (Q4 and full year 2018 comparisons to prior year’s period)Q4 net sales decreased 15.8% to $7.5 million with 2018 net sales increasing 9.9% to $32.3 million.Q4 gross margin decreased to 31.6% from 36.6% with 2018 gross margin increasing to 36.0% from 34.8%.Tariffs in Q4 2018 reduced gross margins, and contributed to a decline in revenue as the Company raised some prices in an attempt to mitigate the tariffs’ negative impact on gross margins.Q4 net loss was approximately $826 thousand, or $0.05 per share, compared to a net loss of $387 thousand, or $0.03 per share, for Q4 2017. 2018 net loss was $74 thousand, or $0.00 per share, compared to a net loss of $1.37 million, or $0.09 per share, for 2017.2018 Fourth Quarter Financial ReviewNet sales for Q4 2018 decreased to $7.5 million from $8.9 million for Q4 2017. This was primarily due to reduced shelf space at one major retailer and price competition exacerbated by the Company’s attempt to increase some product prices in response to 10% China tariffs which began on September 24, 2018. The Company reacted more quickly than its competitors to the tariffs, which reduced revenues for the period. Cable modem sales declined, but the Company did experience increases in its sales of local area network and DSL products.Gross profit for Q4 2018 was $2.4 million, or 31.6% of net sales, down from $3.2 million, or 36.6% of net sales for the fourth quarter of 2017. The decrease in gross profit and gross margin was primarily due to a 10% tariff on the cost of goods for almost all its products other than ones imported into the US prior to September 24, 2018.Operating expenses for Q4 2018 were $3.1 million or 41.8% of net sales, versus $3.6 million or 40.5% of net sales for Q4 2017. Selling expenses increased approximately $58 thousand to $1.96 million for the fourth quarter of 2018, as increased Motorola trademark royalty costs and marketing funds were offset by reductions in advertising and freight costs. General and administrative expenses decreased approximately $522 thousand to $589 thousand for the fourth quarter of 2018, primarily because sales tax expenses dropped $831 thousand due to a significant one-time charge for Q4 2017. This improvement was offset by increased salary and stock option costs, and increases in legal and outside service expenses for the current quarter. Research and development expenses were $573 thousand for Q4 2018, down slightly from $577 thousand in the same period of 2017, as increased personnel costs were offset by reductions in certification expenses.Zoom reported a net loss of $826 thousand or $0.05 per share for the fourth quarter of 2018, compared to net loss of $387 thousand or $0.03 per share in the same period of 2017. 2018 Financial ReviewNet sales for year 2018 increased 9.9% to $32.3 million from $29.4 million for 2017. Sales through all but one of Zoom’s major retailers increased, but reduced sales at one retailer reduced total cable modem sales growth to just 3%. Sales of all other products combined rose over 180% primarily due to rising sales in routers, MoCA adapters, and DSL products.Gross profit in 2018 was $11.6 million or 36.0% of net sales, up from $10.2 million or 34.8% of net sales for year 2017. The increase in gross profit and gross margin was primarily due to higher net sales and a higher mix of e-tailer sales, offset somewhat by tariff-related gross margin reductions in Q4 2018.Operating expenses in 2018 were $11.6 million or 35.9% of net sales, versus $11.5 million or 38.9% of net sales in 2017. Selling expenses increased approximately $927 thousand to $8.2 million for the year, as increased Motorola trademark royalty, advertising, and personnel costs were ...
Bedminster, NJ - (NewMediaWire) - February 28, 2019 - Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) announces the appointment of Peter D. Horst and Patrick J. Mullen to the Board of Directors of the Company and of Peapack-Gladstone Bank, effective February 28, 2019. Peter Horst is a Fortune 500 Chief Marketing Officer with 30 years of marketing leadership experience across diverse industries in consumer and business products, services and technology for market leaders such as Capital One, General Mills, US West (Century Link), Hershey and Ameritrade. He is the founder of CMO, Inc., and serves as a consultant, author, speaker, board member and advisor to senior executives on marketing strategy, messaging and growth planning. Patrick Mullen is a highly experienced financial services professional with a distinguished history of team building and effective relationship management. He is an accomplished and seasoned leader, who recently retired as the Director of Banking, State of New Jersey, for the New Jersey Department of Banking and Insurance, for which he worked over the past eight years. There, among other things, he was responsible for the examination and supervision of all state-chartered banks and credit unions and state-licensed non-bank financial institutions.“Peter and Patrick are joining our Board at the perfect time,” commented F. Duffield Meyercord, Chairman of the Board. “They both bring an elevated level of expertise and perspective in their respective fields. Peter’s extensive brand knowledge will assist us as we continue to introduce Peapack Private, our wealth management brand, to the market; and Patrick’s career with the New Jersey Department of Banking and Insurance will prove invaluable as we continue to navigate our industry’s regulatory challenges.” Peter, a resident of McLean, Virginia, is a graduate of Harvard University and Dartmouth College’s Tuck School of Business. He is a Forbes contributor and author of the best-selling book, Marketing in the #FakeNews Era. Patrick, a resident of Spring Lake, NJ, earned his Master’s Degree from Ball State University and his Bachelor of Arts from St. Francis College. His career in financial services included time spent at Chemical Bank, A.G. Becker, Inc., Kidder Peabody, Inc., Barclays Capital/BZW Securities, ABN AMRO, Inc., Alliance Capital and Sound Securities, LLC, before landing at the New Jersey Department of Banking and Insurance.ABOUT THE CORPORATIONPeapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $4.62 billion and assets under management and/or administration of $5.8 billion as of December 31, 2018. Founded in 1921, Peapack-Gladstone Bank is a commercial bank that provides innovative private banking services to businesses, non-profits and consumers, which help them to establish, maintain and expand their legacy. Through Peapack Private Wealth Management, and its private banking locations in Bedminster, Gladstone, Fairfield, Morristown, New Providence, Princeton and Teaneck, and its trust office in Greenville, DE, Peapack-Gladstone Bank offers an unparalleled commitment to client service through its private wealth management, commercial private banking, retail private banking and residential lending divisions, along with its online platforms. Contact: Denise M. Pace-Sanders Senior Vice President Brand and Marketing Director dpace@pgbank.com 908.470.3322 Peapack-Gladstone Bank 500 Hills Drive, Suite 300 Bedminster, NJ 07921
Merakris Therapeutics’ Lead Scientist, Sam Fagg MSc, PhD, Presents the Research Triangle Park-based Company’s Amniotic Stem Cell Co-culture Raleigh, NC - (NewMediaWire) - February 28, 2019 - Merakris Therapeutics has developed a system designed to mimic cell-cell interactions in utero to produce maximal secreted protein output that is harvested from co-cultured stem cells. Initial experiments indicate it is a strong candidate to support early-phase wound healing. The company’s innovative system mimics the amniotic environment through the co-culturing of amniotic epithelial cells with amniotic fluid cells, which generates a more robust secreted proteome than either cell type alone. The company's research has shown the product activates epithelial to mesenchymal transition, a critical step in early phase wound closure. Additionally, a complementary technique the company has developed also supports late-phase wound healing events known as re-epithelialization and keratinization. Merakris Therapeutics is developing multiple regenerative medicine approaches by using stem cell secreted factors rather than live stem cells. This focus is intended to produce solutions that are scalable, stable, and contain well-characterized target therapeutic components with various applications in disease treatment as well as potential use in cosmetic applications. The company also presented research based on its purified amniotic fluid exosome technology it is developing. The results of this research indicate that exosomes isolated from amniotic fluid promote wound healing in an in vitro assay as efficiently as total amniotic fluid. It has also developed a topical hydrogel system to provide an optimal carrier for these amniotic exosomes that shows promising results in reducing the signs of skin aging in its proof of concept studies. The company has filed multiple patents to protect its research and development discoveries.Currently, Merakris Therapeutics supplies amniotic tissue allografts to various healthcare markets and is working to develop a comprehensive market access program for its Dermacyte® Regenerative Wound Care product line to support product adoption into physician offices. Merakris Therapeutics, based in Research Triangle Park, North Carolina, is focused on researching, developing, and marketing regenerative healthcare products. Merakris is pioneering commercially scalable biotherapeutic technologies derived from stem cells that have various clinical applications. Our vision is to improve global patient care and outcomes through the pioneering and innovation of extracellular regenerative biotechnologies.Chris Broderick 919-921-8105 x 110 broderick@merakris.com
Nashville, TN - (NewMediaWire) - February 28, 2019 - LIG Assets, Inc. (OTC PINK: LIGA) (also known as the "Leader in Green Assets" or "LIGA") announces that on February 19, 2019 the Nashville City Council along with the Planning and Zoning Committee approved the change in zoning for LIGA’s “Bella Serra” development in Brentwood, Tennessee. Formerly the property was zoned AR2a but has now been re-zoned as RS10 and RM4 permitting a denser build out. With this change we will now be implementing our announced plans for the building of condos and single-family homes.LIG Assets President Marvin Baker stated, “We appreciate the thoughtful and exhaustive review of the City Council. These efforts afford LIGA the opportunity to bring to the community a truly landmark sustainable development whose aesthetic beauty will be a true asset to the community. The approval of re-zoning also adds substantial value to this important LIG Assets.” LIG Assets’ management has been fielding multiple calls from potential financing partners who are presenting far superior terms that will help expedite the development and improve the profit margins for the Company. As previously reported the projected gross sales for Bella Serra are anticipated to reach $52,470,000 upon build out of the property. The current Phase One site plan will include 90 residential units total with 10 luxury single-family homes and 80 multi-family “Lifestyle Condos.” The condo/luxury home mix in the current plan may be modified to optimize the development goals. LIGA will be finalizing the site plan to maximize the Bella Serra development for the greatest benefit of the company and our shareholders.Chairman Aric Simons added, “The re-zoning for Bella Serra is an important step forward to achieving our corporate mission of bringing sustainable, beautiful residences to the community at a market competitive price point. We shall continue to prove that sustainable building is better for families, the environment and is good business. The management of LIGA believes we have the best shareholder base for any public company on the market; we aim to reward the loyalty and enthusiasm of our investors with exponential ROI and a company each can be proud to hold in their portfolio.Bella Serra – Brentwood, Tennessee:A Luxury Mediterranean hillside resort development offering the variety of custom single-family homes and the simplistic lifestyle living of condominium villas for the most discerning buyers of luxury living at its finest. The most unique feature of these homes will be the green sustainability factor built with consideration of the environment in mind. A high quality luxury resort lifestyle community with wellness in mind while reducing carbon emissions and energy consumption to improve our quality of life. Derived from the Latin/Italian influence Bella meaning beautiful and Serra meaning views from a high place or high ridge as our community rests at one of the highest peaks in Brentwood with our ridgeline facing south into Brentwood/Franklin and the lower lined development facing toward Nashville.Bella Serra is a concept development using sustainable building products brought to us by well-known Environmentalist Robert Plarr. Bella Serra will be Nashville and Middle Tennessee’s first fully sustainable community. A new approach to residential build application using light gauge steel framing versus wood framing with our high-quality magnesium oxide panels where the combination creates a sustainable structure resistant to 185 mph winds, water and mold resistant, fire resistant to 3500 degrees with a burn rate of 5 hours before the material begins to breakdown.About LIGA Homes:LIGA Homes unique residential and commercial developments utilize specially designed and manufactured recycled "element resistant" steel framing, in addition to toxic free magnesium oxide building materials and panels that are 100% mold, fungus, termite and rot resistant and fire resistant against temperatures up to 3500 degrees Fahrenheit as well as famed environmentalist Robert ...
